Media ReleasesStar Combo Pharma

View All Star Combo Pharma News

Star Combo, 2018 AGM Chairman's Address and CEO Presentation

2018 was a transformational year for Star Combo and we achieved a great deal.

At the beginning of calendar year 2018 we embarked upon the IPO for the company. This was a process designed to raise funds to set the company up with the resources to grow our branded products, to expand our factory utilisation, and to open new sales channels. It was also aimed at providing us with the financial means to look at strategically aligned business acquisitions, which I will talk about more in a few minutes. The IPO was a tremendous success and we are very grateful for the support that the investing community has given us prior to and subsequent to listing in May this year. For that I thank you.

For further information please download PDF attached:
Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.